Literature DB >> 8522671

The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis.

P Rieder1, M Louis, P Jolliet, J C Chevrolet.   

Abstract

OBJECTIVE: Testing the hypothesis that, in myasthenia gravis (MG), repeated measurements of vital capacity (VC) and various parameters derived from this measurement [median or lowest value of measured VCs during hospitalization, VC values < 20 ml/kg body weight (BW) or < 13 ml/kg BW, or an index assessing the variability of VC values during the whole ICU stay] could predict the need for intubation and mechanical ventilation (MV), as has been shown in other neuromuscular diseases with respiratory failure.
DESIGN: Retrospective study with medical chart revision of all the patients with MG and respiratory failure admitted to our intensive care unit between 1985 and 1993.
SETTING: Medical intensive care unit (15 beds) of a university hospital. PATIENTS AND METHODS: Five patients suffering from ten episodes of acute respiratory failure due to their decompensated MG. Repeated measurements of arterial blood gases and VC by trained respiratory therapists, at least every 4 h.
RESULTS: There was no difference in any of these parameters between patients eventually requiring MV (four episodes) and those in whom mechanical ventilation was not necessary (six episodes).
CONCLUSIONS: VC repeated measurements is a poor predictor of the need for further MV in MG patients. This can probably be ascribed to the erratic nature of MG, a disease whose course is largely influenced by many parameters (infection, treatment modifications, initiation of corticosteroid therapy, stress, psychological factors, etc.). Early admissions to the ICU of MG patients with respiratory dysfunction is thus recommended.

Entities:  

Mesh:

Year:  1995        PMID: 8522671     DOI: 10.1007/bf01711545

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  27 in total

1.  Control of breathing in patients with myasthenia gravis.

Authors:  A Spinelli; G Marconi; M Gorini; A Pizzi; G Scano
Journal:  Am Rev Respir Dis       Date:  1992-06

2.  Predicting the need for postoperative mechanical ventilation in myasthenia gravis.

Authors:  J B Eisenkraft; A E Papatestas; C H Kahn; C T Mora; R Fagerstrom; G Genkins
Journal:  Anesthesiology       Date:  1986-07       Impact factor: 7.892

3.  Respiratory mechanics in untreated myasthenia gravis with special reference to the respiratory forces.

Authors:  I Ringqvist; T Ringqvist
Journal:  Acta Med Scand       Date:  1971-12

Review 4.  Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients.

Authors:  K E Osserman; G Genkins
Journal:  Mt Sinai J Med       Date:  1971 Nov-Dec

5.  Extubation after transsternal thymectomy for myasthenia gravis: a prospective analysis.

Authors:  M S Gorback; R E Moon; J M Massey
Journal:  South Med J       Date:  1991-06       Impact factor: 0.954

6.  Changes in selected pulmonary functions in patients diagnosed with myasthenia gravis.

Authors:  M Litchfield; E Noroian
Journal:  J Neurosci Nurs       Date:  1989-12       Impact factor: 1.230

7.  Myasthenia gravis: determinants for independent ventilation after transsternal thymectomy.

Authors:  D S Younger; N M Braun; A Jaretzki; A S Penn; R E Lovelace
Journal:  Neurology       Date:  1984-03       Impact factor: 9.910

8.  Preoperative lumbar epidural morphine improves postoperative analgesia and ventilatory function after transsternal thymectomy in patients with myasthenia gravis.

Authors:  J R Kirsch; M N Diringer; C O Borel; D F Hanley; W T Merritt; G B Bulkley
Journal:  Crit Care Med       Date:  1991-12       Impact factor: 7.598

9.  Postoperative respiratory care after transsternal thymectomy in myasthenia gravis. A 3-year experience in 53 patients.

Authors:  D R Gracey; M B Divertie; F M Howard; W S Payne
Journal:  Chest       Date:  1984-07       Impact factor: 9.410

10.  Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barré syndrome.

Authors:  J C Chevrolet; P Deléamont
Journal:  Am Rev Respir Dis       Date:  1991-10
View more
  16 in total

Review 1.  Myasthenic crisis.

Authors:  David Lacomis
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

2.  Risk of extubation failure in patients with myasthenic crisis.

Authors:  Alejandro A Rabinstein; Nils Mueller-Kronast
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

3.  Myasthenic crisis.

Authors:  Linda C Wendell; Joshua M Levine
Journal:  Neurohospitalist       Date:  2011-01

4.  Predictive value of ventilatory tests in myasthenia gravis.

Authors:  A Grad; V Svigelj
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

Review 5.  Acute lung failure.

Authors:  Rob Mac Sweeney; Daniel F McAuley; Michael A Matthay
Journal:  Semin Respir Crit Care Med       Date:  2011-10-11       Impact factor: 3.119

6.  Respiratory Muscle Assessment in Acute Guillain-Barré Syndrome.

Authors:  S Walterspacher; A Kirchberger; J Lambeck; D J Walker; A Schwörer; W D Niesen; W Windisch; F Hamzei; H J Kabitz
Journal:  Lung       Date:  2016-08-09       Impact factor: 2.584

Review 7.  Airway management in neurological emergencies.

Authors:  Lynn P Roppolo; Karina Walters
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

8.  An Update on Myasthenic Crisis.

Authors:  Shafiuddin Ahmed; Jawad F Kirmani; Nazli Janjua; Ammar Alkawi; Ismail Khatri; Abutaher M Yahia; Nizar Souyah; Adnan I Qureshi
Journal:  Curr Treat Options Neurol       Date:  2005-03       Impact factor: 3.598

9.  The role of non-invasive ventilation and factors predicting extubation outcome in myasthenic crisis.

Authors:  Jenn-Yu Wu; Ping-Hung Kuo; Pi-Chuan Fan; Huey-Dong Wu; Fuh-Yuan Shih; Pan-Chyr Yang
Journal:  Neurocrit Care       Date:  2008-09-20       Impact factor: 3.210

10.  Myasthenic Crisis.

Authors:  Jawad F. Kirmani; Abutaher M. Yahia; Adnan I. Qureshi
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.